<?xml version="1.0"?>
<!DOCTYPE BlastOutput PUBLIC "-//NCBI//NCBI BlastOutput/EN" "http://www.ncbi.nlm.nih.gov/dtd/NCBI_BlastOutput.dtd">
<BlastOutput>
  <BlastOutput_program>blastp</BlastOutput_program>
  <BlastOutput_version>BLASTP 2.8.1+</BlastOutput_version>
  <BlastOutput_reference>Stephen F. Altschul, Thomas L. Madden, Alejandro A. Sch&amp;auml;ffer, Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997), &quot;Gapped BLAST and PSI-BLAST: a new generation of protein database search programs&quot;, Nucleic Acids Res. 25:3389-3402.</BlastOutput_reference>
  <BlastOutput_db>nr</BlastOutput_db>
  <BlastOutput_query-ID>Query_144245</BlastOutput_query-ID>
  <BlastOutput_query-def>2HNTE</BlastOutput_query-def>
  <BlastOutput_query-len>81</BlastOutput_query-len>
  <BlastOutput_param>
    <Parameters>
      <Parameters_matrix>BLOSUM62</Parameters_matrix>
      <Parameters_expect>10</Parameters_expect>
      <Parameters_gap-open>11</Parameters_gap-open>
      <Parameters_gap-extend>1</Parameters_gap-extend>
      <Parameters_filter>F</Parameters_filter>
    </Parameters>
  </BlastOutput_param>
<BlastOutput_iterations>
<Iteration>
  <Iteration_iter-num>1</Iteration_iter-num>
  <Iteration_query-ID>Query_144245</Iteration_query-ID>
  <Iteration_query-def>2HNTE</Iteration_query-def>
  <Iteration_query-len>81</Iteration_query-len>
<Iteration_hits>
<Hit>
  <Hit_num>1</Hit_num>
  <Hit_id>gi|1173196308|pdb|5TO3|B</Hit_id>
  <Hit_def>Chain B, Crystal Structure Of Thrombin Mutant W215a/e217a Fused To Egf456 Of Thrombomodulin Via A 31-residue Linker And Bound To Ppack</Hit_def>
  <Hit_accession>5TO3_B</Hit_accession>
  <Hit_len>409</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>182.57</Hsp_bit-score>
      <Hsp_score>462</Hsp_score>
      <Hsp_evalue>2.17724e-54</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>2</Hit_num>
  <Hit_id>gi|809213|pdb|2HNT|E</Hit_id>
  <Hit_def>Chain E, Crystallographic Structure Of Human Gamma-Thrombin</Hit_def>
  <Hit_accession>2HNT_E</Hit_accession>
  <Hit_len>81</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.4</Hsp_bit-score>
      <Hsp_score>433</Hsp_score>
      <Hsp_evalue>4.97194e-54</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>81</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>3</Hit_num>
  <Hit_id>gi|119588384|gb|EAW67978.1|</Hit_id>
  <Hit_def>coagulation factor II (thrombin), isoform CRA_b [Homo sapiens]</Hit_def>
  <Hit_accession>EAW67978</Hit_accession>
  <Hit_len>556</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>179.489</Hsp_bit-score>
      <Hsp_score>454</Hsp_score>
      <Hsp_evalue>6.65201e-52</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>437</Hsp_hit-from>
      <Hsp_hit-to>517</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>4</Hit_num>
  <Hit_id>gi|51247713|pdb|1TQ0|B</Hit_id>
  <Hit_def>Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin Mutant W215aE217A IN FREE FORM &gt;gi|51247715|pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin Mutant W215aE217A IN FREE FORM &gt;gi|51247717|pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant W215aE217A Bound To Ppack</Hit_def>
  <Hit_accession>1TQ0_B</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.014</Hsp_bit-score>
      <Hsp_score>432</Hsp_score>
      <Hsp_evalue>1.17995e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>5</Hit_num>
  <Hit_id>gi|251836913|pdb|3EE0|B</Hit_id>
  <Hit_def>Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN Thrombin (Space Group P2(1)2(1)2(1)) &gt;gi|251837022|pdb|3HKJ|B Chain B, Crystal structure of human thrombin mutant W215A/E217A in complex with the extracellular fragment of human PAR1 &gt;gi|251837025|pdb|3HKJ|E Chain E, Crystal structure of human thrombin mutant W215A/E217A in complex with the extracellular fragment of human PAR1 &gt;gi|38018092|gb|AAR08143.1| prothrombin B-chain, partial [Homo sapiens]</Hit_def>
  <Hit_accession>3EE0_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.4</Hsp_bit-score>
      <Hsp_score>433</Hsp_score>
      <Hsp_evalue>1.18302e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>6</Hit_num>
  <Hit_id>gi|146387601|pdb|2OD3|B</Hit_id>
  <Hit_def>Chain B, Human Thrombin Chimera With Human Residues 184a, 186, 186a, 186b, 186c And 222 Replaced By Murine Thrombin Equivalents.</Hit_def>
  <Hit_accession>2OD3_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.014</Hsp_bit-score>
      <Hsp_score>432</Hsp_score>
      <Hsp_evalue>1.20906e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>7</Hit_num>
  <Hit_id>gi|152149317|pdb|2PGB|B</Hit_id>
  <Hit_def>Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a &gt;gi|152149319|pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-c220a In Complex With The Inhibitor Ppack</Hit_def>
  <Hit_accession>2PGB_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.014</Hsp_bit-score>
      <Hsp_score>432</Hsp_score>
      <Hsp_evalue>1.42355e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>8</Hit_num>
  <Hit_id>gi|73536044|pdb|2A0Q|B</Hit_id>
  <Hit_def>Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride &gt;gi|73536046|pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride</Hit_def>
  <Hit_accession>2A0Q_B</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.014</Hsp_bit-score>
      <Hsp_score>432</Hsp_score>
      <Hsp_evalue>1.54914e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>9</Hit_num>
  <Hit_id>gi|6435720|pdb|1QUR|H</Hit_id>
  <Hit_def>Chain H, Human Alpha-Thrombin In Complex With Bivalent, Benzamidine-Based Synthetic Inhibitor &gt;gi|10835391|pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With Benzothiophene Inhibitor 4 &gt;gi|18655576|pdb|1EB1|H Chain H, Complex structure of human thrombin with N-methyl-arginine inhibitor &gt;gi|18655740|pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A Multi-centered Short Hydrogen Bonding Network At The Active Site &gt;gi|88191864|pdb|1YPE|H Chain H, Thrombin Inhibitor Complex &gt;gi|88191867|pdb|1YPG|H Chain H, Thrombin Inhibitor Complex &gt;gi|88191870|pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex &gt;gi|88191873|pdb|1YPK|H Chain H, Thrombin Inhibitor Complex &gt;gi|88191876|pdb|1YPL|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic Cyanopeptide Analogue Ra-1008 &gt;gi|88191879|pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic Cyanopeptide Analogue Ra-1014 &gt;gi|110590819|pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor With Human Thrombin And A C-terminal Hirudin Derived Exo-sit Inhibitor &gt;gi|110590949|pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With An Inhibitor &gt;gi|157877655|pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A Multi-centered Short Hydrogen Bonding Network At The Active Site &gt;gi|157877660|pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A Multi-Centered Short Hydrogen Bonding Network At The Active Site &gt;gi|157881466|pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With An Inhibitor &gt;gi|157881486|pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed Inhibitor &gt;gi|163931190|pdb|3BIU|H Chain H, Human Thrombin-in Complex With Ub-thr10 &gt;gi|163931193|pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11 &gt;gi|192988238|pdb|2V3H|H Chain H, Thrombin With 3-cycle No F &gt;gi|192988242|pdb|2V3O|H Chain H, Thrombin With 3-cycle With F &gt;gi|392311694|pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240 &gt;gi|400977388|pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex &gt;gi|400977391|pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex &gt;gi|400977394|pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex &gt;gi|449120879|pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A Multi-centered Short Hydrogen Bonding Network At The Active Site &gt;gi|645985732|pdb|4LOY|H Chain H, Crystal Structure Analysis Of Thrombin In Complex With Compound D57, 5-chlorothiophene-2-carboxylic Acid [(s)-2-[2-methyl-3-(2- Oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1- Yl)- 3-oxopropyl]amide (sar107375)</Hit_def>
  <Hit_accession>1QUR_H</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.014</Hsp_bit-score>
      <Hsp_score>432</Hsp_score>
      <Hsp_evalue>1.5661e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>10</Hit_num>
  <Hit_id>gi|66360194|pdb|1TWX|B</Hit_id>
  <Hit_def>Chain B, Crystal Structure Of The Thrombin Mutant D221a/d222k</Hit_def>
  <Hit_accession>1TWX_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.014</Hsp_bit-score>
      <Hsp_score>432</Hsp_score>
      <Hsp_evalue>1.60466e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>11</Hit_num>
  <Hit_id>gi|49258977|pdb|1SFQ|B</Hit_id>
  <Hit_def>Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack &gt;gi|49258979|pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack &gt;gi|49258984|pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of Thrombin &gt;gi|49258986|pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of Thrombin &gt;gi|49258988|pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of Thrombin &gt;gi|49258990|pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of Thrombin &gt;gi|49258995|pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack &gt;gi|49258997|pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack &gt;gi|116667879|pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen Gamma&apos; Peptide &gt;gi|116667881|pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen Gamma&apos; Peptide &gt;gi|169404722|pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19</Hit_def>
  <Hit_accession>1SFQ_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.014</Hsp_bit-score>
      <Hsp_score>432</Hsp_score>
      <Hsp_evalue>1.65793e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>12</Hit_num>
  <Hit_id>gi|67464370|pdb|1Z8I|B</Hit_id>
  <Hit_def>Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To Ppack</Hit_def>
  <Hit_accession>1Z8I_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>170.629</Hsp_bit-score>
      <Hsp_score>431</Hsp_score>
      <Hsp_evalue>1.71298e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>13</Hit_num>
  <Hit_id>gi|6980889|pdb|1B7X|B</Hit_id>
  <Hit_def>Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D- Phe-Pro-Arg-Chloromethylketone</Hit_def>
  <Hit_accession>1B7X_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>170.629</Hsp_bit-score>
      <Hsp_score>431</Hsp_score>
      <Hsp_evalue>1.71298e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>14</Hit_num>
  <Hit_id>gi|4699868|pdb|2THF|B</Hit_id>
  <Hit_def>Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To D-phe-pro-arg- Chloromethylketone</Hit_def>
  <Hit_accession>2THF_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>170.629</Hsp_bit-score>
      <Hsp_score>431</Hsp_score>
      <Hsp_evalue>1.75068e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>15</Hit_num>
  <Hit_id>gi|1048348447|pdb|5JDU|B</Hit_id>
  <Hit_def>Chain B, Crystal Structure For Human Thrombin Mutant D189a &gt;gi|1048348449|pdb|5JDU|D Chain D, Crystal Structure For Human Thrombin Mutant D189a</Hit_def>
  <Hit_accession>5JDU_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>170.629</Hsp_bit-score>
      <Hsp_score>431</Hsp_score>
      <Hsp_evalue>1.75068e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>16</Hit_num>
  <Hit_id>gi|493792|pdb|1ABI|H</Hit_id>
  <Hit_def>Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of The S&apos; Subsites Of Substrates And Inhibitors &gt;gi|493795|pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of The S&apos; Subsites Of Substrates And Inhibitors &gt;gi|493986|pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of The Binding To Human Thrombin Of Four Active Site-directed Inhibitors &gt;gi|493989|pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of The Binding To Human Thrombin Of Four Active Site-Directed Inhibitors &gt;gi|493992|pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of The Binding To Human Thrombin Of Four Active Site-Directed Inhibitors &gt;gi|493995|pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of The Binding To Human Thrombin Of Four Active Site-Directed Inhibitors &gt;gi|494028|pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural Basis For Its Specificity &gt;gi|494150|pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha- Thrombin &gt;gi|494206|pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin And Non- Hydrolyzable Bifunctional Inhibitors, Hirutonin-2 And Hirutonin-6 &gt;gi|494209|pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin And Non- Hydrolyzable Bifunctional Inhibitors, Hirutonin-2 And Hirutonin-6 &gt;gi|494462|pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human Alpha-Thrombin: Interaction With D-Phe-Pro-Arg Chloromethylketone And Significance Of The Tyr-Pro-Pro-Trp Insertion Segment &gt;gi|494647|pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A Natural Exosite Inhibitor &gt;gi|494650|pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A Natural Exosite Inhibitor &gt;gi|494655|pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin By The Macrocyclic Peptide Cyclotheonamide A &gt;gi|494778|pdb|2HGT|H Chain H, STRUCTURE OF THE HIRUGEN AND HIRULOG 1 COMPLEXES OF ALPHA-THROMBIN &gt;gi|494783|pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin &gt;gi|494787|pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And Bovine Prothrombin Fragment 2 With Human Ppack-thrombin &gt;gi|494874|pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And Human Alpha-Thrombin &gt;gi|494908|pdb|4HTC|H Chain H, THE REFINED STRUCTURE OF THE HIRUDIN-THROMBIN COMPLEX &gt;gi|576170|pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer Single-Stranded Dna Aptamer &gt;gi|576204|pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With Thrombin Receptor Peptides: Existence Of Expected And Novel Binding Modes &gt;gi|576207|pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With Thrombin Receptor Peptides: Existence Of Expected And Novel Binding Modes &gt;gi|576210|pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With Thrombin Receptor Peptides: Existence Of Expected And Novel Binding Modes &gt;gi|576213|pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With Thrombin Receptor Peptides: Existence Of Expected And Novel Binding Modes &gt;gi|576216|pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With Thrombin Receptor Peptides: Existence Of Expected And Novel Binding Modes &gt;gi|576220|pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With Thrombin Receptor Peptides: Existence Of Expected And Novel Binding Modes &gt;gi|640434|pdb|1TMT|H Chain H, CHANGES IN INTERACTIONS IN COMPLEXES OF HIRUDIN DERIVATIVES AND HUMAN ALPHA-THROMBIN DUE TO DIFFERENT CRYSTAL FORMS &gt;gi|640438|pdb|1TMU|H Chain H, Thrombin heavy chain &gt;gi|809132|pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain Of Thrombomodulin Complexed With Thrombin &gt;gi|809135|pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain Of Thrombomodulin Complexed With Thrombin &gt;gi|809453|pdb|1HAH|H Chain H, THE ISOMORPHOUS STRUCTURES OF PRETHROMBIN2, HIRUGEN-AND PPACK-THROMBIN: CHANGES ACCOMPANYING ACTIVATION AND EXOSITE BINDING TO THROMBIN &gt;gi|809456|pdb|1HAI|H Chain H, THE ISOMORPHOUS STRUCTURES OF PRETHROMBIN2, HIRUGEN-AND PPACK-THROMBIN: CHANGES ACCOMPANYING ACTIVATION AND EXOSITE BINDING TO THROMBIN &gt;gi|999721|pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin &gt;gi|999824|pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin &gt;gi|1065046|pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium Methyl Ketone Containing Bivalent Inhibitor &gt;gi|1311348|pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed With Human Alpha-Thrombin &gt;gi|1421172|pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of Dna) &gt;gi|1421184|pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of Dna) &gt;gi|1421284|pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms Resolution &gt;gi|1633538|pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin &gt;gi|1942044|pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen &gt;gi|1942457|pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant &gt;gi|1943088|pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With [s-(R,R)]-4-[(Aminoiminomethyl) Amino]-N-[[1-[3-Hydroxy-2-[(2-Naphthalenylsulfonyl)amino]-1- Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide (Bms-186282) &gt;gi|1943091|pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With [s-(R,R)]-1-(Aminoiminomethyl)- N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-Pyrrolidinyl]methyl]-3- Piperidenecarboxamide (Bms-189090) &gt;gi|1943459|pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine &gt;gi|1943474|pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With Ac-(d)phe-pro-borolys-oh &gt;gi|1943477|pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N- Butyl-Amidino-Glycine-Oh &gt;gi|1943480|pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro- Homolys-Oh &gt;gi|1943483|pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro- Boroornithine-Oh &gt;gi|1943530|pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boroarg-Oh &gt;gi|2624617|pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel P1 Moiety &gt;gi|2624871|pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite Inhibitor Hirugen And Active Site Inhibitor Phch2oco-D-Dpa-Pro-Borompg &gt;gi|2624876|pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite Inhibitor Hirugen And Active Site Inhibitor Phch2oco-D-Dpa-Pro-Boroval &gt;gi|2781260|pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By Eoc-D-Phe-Pro-Azalys-Onp &gt;gi|2781263|pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp &gt;gi|2781295|pdb|1UVS|H Chain H, BOVINE THROMBIN--BM51.1011 COMPLEX &gt;gi|2914466|pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure Of Human Alpha-Thrombin:hirunorm V Complex &gt;gi|2981772|pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based Macrocyclic Tripeptide Motif &gt;gi|3212333|pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic Inhibitor &gt;gi|3212360|pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing Inhibitors: Probes Of The S1&apos; Binding Site &gt;gi|3212372|pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide Mimetic Inhibitor And Hirugen &gt;gi|3212496|pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide Mimetic Inhibitor And Hirugen &gt;gi|3212619|pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D Phenylalanyl-N-[5- (Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl] Butyl]-L- Prolinamide Trifluroacetate And Exosite-Hirugen &gt;gi|3318750|pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-a From A Blue-green Alga &gt;gi|3318985|pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing Inhibitor &gt;gi|3319062|pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional Boronate Inhibitor Borolog1 &gt;gi|3319065|pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional Boronate Inhibitor Borolog2 &gt;gi|3891595|pdb|1AWF|H Chain H, NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT &gt;gi|3891598|pdb|1AWH|B Chain B, NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT &gt;gi|3891600|pdb|1AWH|D Chain D, NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT &gt;gi|3891955|pdb|1BCU|H Chain H, ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND PROFLAVIN &gt;gi|4699691|pdb|8KME|2 Chain 2, CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH SEL2770. &gt;gi|4929904|pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes &gt;gi|4929910|pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes &gt;gi|4929962|pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes &gt;gi|5542573|pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv Complex Reveals A Novel Specificity Site Recognition Mode. &gt;gi|6435561|pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An Guanidine-mimetic Inhibitor &gt;gi|6435757|pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With 5- Amidinoindole-4-benzylpiperidine Inhibitor &gt;gi|7246027|pdb|7KME|H Chain H, CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH SEL2711. &gt;gi|8569363|pdb|1QHR|B Chain B, NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS &gt;gi|9257022|pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors &gt;gi|9257029|pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors &gt;gi|9257032|pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors &gt;gi|10835394|pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With Benzo[b]thiophene Inhibitor 3 &gt;gi|10835397|pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With Benzo[b]thiophene Inhibitor 2 &gt;gi|10835400|pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With Benzo[b]thiophene Inhibitor 1 &gt;gi|10835492|pdb|1C4U|2 Chain 2, SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES. &gt;gi|10835495|pdb|1C4V|2 Chain 2, SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES. &gt;gi|11514706|pdb|1C4Y|2 Chain 2, SELECTIVE NON-ELECTROPHILIC THROMBIN INHIBITORS &gt;gi|12084432|pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With Alpha-Thrombin: Crystal Structure Of The Enzyme-Substrate Complex &gt;gi|12084434|pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With Alpha-Thrombin: Crystal Structure Of The Enzyme-Substrate Complex &gt;gi|16975148|pdb|1G30|B Chain B, THROMBIN INHIBITOR COMPLEX &gt;gi|16975151|pdb|1G32|B Chain B, Thrombin Inhibitor Complex &gt;gi|18655491|pdb|1KTS|B Chain B, Thrombin Inhibitor Complex &gt;gi|18655494|pdb|1KTT|B Chain B, Thrombin Inhibitor Complex &gt;gi|21465763|pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex &gt;gi|21465766|pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex &gt;gi|28949036|pdb|1NY2|2 Chain 2, Human alpha thrombin inhibited by RPPGF and hirugen &gt;gi|31615744|pdb|1O2G|H Chain H, Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors &gt;gi|33357811|pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed Fluorinated Inhibitor &gt;gi|34810220|pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating Novel P1 Binding Functions: Molecular And X-Ray Crystallographic Studies. &gt;gi|34811264|pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor Gpib-alpha And Human Alpha-thrombin &gt;gi|34811275|pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor Gpib-alpha And Alpha-thrombin At 2.6a &gt;gi|37927032|pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex &gt;gi|37927035|pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex &gt;gi|38492568|pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor &gt;gi|38492571|pdb|1O0D|H Chain H, Human Thrombin complexed with a d-Phe-Pro-Arg-type Inhibitor and a C-terminal Hirudin derived exo-site inhibitor &gt;gi|47168355|pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622 &gt;gi|47168358|pdb|1MU8|B Chain B, Thrombin-hirugen_l-378,650 &gt;gi|47168361|pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426 &gt;gi|52695557|pdb|1SR5|C Chain C, Antithrombin-anhydrothrombin-heparin Ternary Complex Structure &gt;gi|55669528|pdb|1O5G|H Chain H, Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA) &gt;gi|56967145|pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin &gt;gi|56967147|pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin &gt;gi|56967149|pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin &gt;gi|56967151|pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin &gt;gi|60593850|pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors &gt;gi|62738006|pdb|1T4U|H Chain H, Crystal Structure Analysis of a novel Oxyguanidine bound to Thrombin &gt;gi|62738009|pdb|1T4V|H Chain H, Crystal Structure Analysis of a novel Oxyguanidine bound to Thrombin &gt;gi|83753983|pdb|2AFQ|B Chain B, 1.9 Angstrom Crystal Structure Of Wild-type Human Thrombin In The Sodium Free State &gt;gi|83753985|pdb|2AFQ|D Chain D, 1.9 Angstrom Crystal Structure Of Wild-type Human Thrombin In The Sodium Free State &gt;gi|99031771|pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The Central &quot;e&quot; Region Of Fibrin &gt;gi|99031773|pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The Central &quot;e&quot; Region Of Fibrin &gt;gi|109156904|pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues 54-65) And L- Arginine Template Inhibitor Cs107 &gt;gi|109157608|pdb|2FES|H Chain H, Orally active thrombin inhibitors &gt;gi|112490107|pdb|2C8W|B Chain B, Thrombin Inhibitors &gt;gi|112490111|pdb|2C8X|B Chain B, Thrombin Inhibitors &gt;gi|112490115|pdb|2C8Y|B Chain B, Thrombin Inhibitors &gt;gi|112490120|pdb|2C8Z|B Chain B, Thrombin Inhibitors &gt;gi|112490124|pdb|2C90|B Chain B, Thrombin Inhibitors &gt;gi|112490129|pdb|2C93|B Chain B, Thrombin Inhibitors &gt;gi|114793812|pdb|2FEQ|H Chain H, orally active thrombin inhibitors &gt;gi|118137385|pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-based Small Molecules Occupying The S1 Pocket &gt;gi|118137392|pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors With A Solubilizing Cationic P1-p2-linker &gt;gi|118137395|pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors With A Solubilizing Cationic P1-p2-linker &gt;gi|118137398|pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors With A Solubilizing Cationic P1-p2-linker &gt;gi|119388977|pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors in Complex with Thrombin Inh12 &gt;gi|119388980|pdb|2ANK|H Chain H, orally active thrombin inhibitors in complex with thrombin and an exosite decapeptide &gt;gi|145579364|pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor &gt;gi|149241911|pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With Suramin &gt;gi|149242359|pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex &gt;gi|149242365|pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex &gt;gi|149242370|pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex &gt;gi|157838361|pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of Serine Proteases &gt;gi|157838364|pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of Serine Proteases &gt;gi|157838367|pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of Serine Proteases &gt;gi|157838394|pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule, S1-binding, Sub- Micromolar Inhibitor Of Urokinase Type Plasminogen Activator &gt;gi|157838399|pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule, S1-binding, Sub- Micromolar Inhibitor Of Urokinase Type Plasminogen Activator &gt;gi|157838402|pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule, S1-binding, Sub- Micromolar Inhibitor Of Urokinase Type Plasminogen Activator &gt;gi|157878283|pdb|1HXE|H Chain H, Serine Protease &gt;gi|158430867|pdb|2UUF|B Chain B, Thrombin-hirugen Binary Complex At 1.26a Resolution &gt;gi|158430870|pdb|2UUJ|B Chain B, Thrombin-hirugen-gw473178 Ternary Complex At 1.32a Resolution &gt;gi|158430873|pdb|2UUK|B Chain B, Thrombin-hirugen-gw420128 Ternary Complex At 1.39a Resolution &gt;gi|163931175|pdb|3BF6|H Chain H, Thrombin:suramin Complex &gt;gi|197304957|pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin Inhibitors &gt;gi|208435756|pdb|3EGK|H Chain H, KNOBLE Inhibitor &gt;gi|210060868|pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor &gt;gi|210060871|pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket &gt;gi|210060874|pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket &gt;gi|211939077|pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket &gt;gi|213424253|pdb|3E6P|H Chain H, Crystal structure of human meizothrombin desF1 &gt;gi|218681562|pdb|2ZFF|H Chain H, Exploring Thrombin S1-pocket &gt;gi|218681567|pdb|2ZFP|H Chain H, Thrombin Inibition &gt;gi|218681570|pdb|2ZGB|H Chain H, Thrombin Inhibition &gt;gi|218681577|pdb|2ZGX|H Chain H, Thrombin Inhibition &gt;gi|220702239|pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket &gt;gi|220702242|pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket &gt;gi|220702247|pdb|2ZHQ|H Chain H, Thrombin Inhibition &gt;gi|220702250|pdb|2ZI2|H Chain H, Thrombin Inhibition &gt;gi|220702253|pdb|2ZIQ|H Chain H, Thrombin Inhibition &gt;gi|221046516|pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket &gt;gi|223365740|pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket &gt;gi|223365743|pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket &gt;gi|223365748|pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket &gt;gi|223673888|pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin Inhibitors &gt;gi|226887656|pdb|2ZNK|H Chain H, Thrombin Inhibition &gt;gi|226887660|pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors &gt;gi|226887692|pdb|3D49|H Chain H, Thrombin Inhibition &gt;gi|237823757|pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor &gt;gi|237823760|pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors &gt;gi|241913162|pdb|3DT0|H Chain H, Understanding Thrombin Inhibition &gt;gi|241913173|pdb|3DUX|H Chain H, Understanding Thrombin Inhibition &gt;gi|256032574|pdb|3EQ0|H Chain H, Thrombin Inhibitor &gt;gi|261824819|pdb|3F68|H Chain H, Thrombin Inhibition &gt;gi|334359260|pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib Interaction With Two Distinct Alpha-Thrombin Sites &gt;gi|340707774|pdb|3P6Z|B Chain B, Thrombin heavy chain &gt;gi|340707777|pdb|3P6Z|H Chain H, Thrombin heavy chain &gt;gi|343197144|pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A Thrombin Inhibitor With An Oxyguanidine P1 Motif &gt;gi|347948583|pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation: Essential Role Of The Hirudin-Like Sequence Glu666-Glu672 For Processing At The Heavy Chain-B Domain Junction &gt;gi|347948585|pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation: Essential Role Of The Hirudin-Like Sequence Glu666-Glu672 For Processing At The Heavy Chain-B Domain Junction &gt;gi|347948587|pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation: Essential Role Of The Hirudin-Like Sequence Glu666-Glu672 For Processing At The Heavy Chain-B Domain Junction &gt;gi|347948589|pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation: Essential Role Of The Hirudin-Like Sequence Glu666-Glu672 For Processing At The Heavy Chain-B Domain Junction &gt;gi|350610808|pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With N-(Methylsulfonyl)-D-Phenylalanyl- N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide (Bms-189664) &gt;gi|353251753|pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha Thrombin And A Modified Thrombin Binding Aptamer (Mtba) &gt;gi|355332983|pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives &gt;gi|358009458|pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights Of A Novel Mechanism Of Inhibition And Design Of Tunable Thrombin Inhibitors &gt;gi|378792109|pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives &gt;gi|378792112|pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives &gt;gi|379318290|pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives &gt;gi|380258834|pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives &gt;gi|383875507|pdb|3U69|H Chain H, Unliganded wild-type human thrombin &gt;gi|383875509|pdb|3U8T|H Chain H, Human Thrombin Complexed With D-phe-pro-d-arg-cys &gt;gi|385251697|pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328 &gt;gi|385251700|pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329 &gt;gi|385251705|pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354 &gt;gi|385251710|pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003 &gt;gi|385251713|pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331 &gt;gi|385251716|pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332 &gt;gi|385251719|pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341 &gt;gi|385251722|pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004 &gt;gi|388325704|pdb|3U8O|H Chain H, Human thrombin complexed with D-Phe-Pro-D-Arg-D-Thr &gt;gi|388325706|pdb|3U8R|H Chain H, Human thrombin complexed with D-Phe-Pro-D-Arg-Ile &gt;gi|392311572|pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97 &gt;gi|392311575|pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101 &gt;gi|392311580|pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103 &gt;gi|392311583|pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104 &gt;gi|392311592|pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105 &gt;gi|392311751|pdb|4E7R|H Chain H, Thrombin In Complex With 3-amidinophenylalanine Inhibitor &gt;gi|392311752|pdb|4E7R|G Chain G, Thrombin In Complex With 3-amidinophenylalanine Inhibitor &gt;gi|395759363|pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha Thrombin And Thrombin Binding Aptamer In The Presence Of Sodium Ions &gt;gi|395759366|pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha Thrombin And Thrombin Binding Aptamer In The Presence Of Potassium Ions &gt;gi|399124871|pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340 &gt;gi|402550134|pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin &gt;gi|409973695|pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001 &gt;gi|409973698|pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330 &gt;gi|427930814|pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin Through A Novel Reverse-Binding Mechanism &gt;gi|427930818|pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin Through A Novel Reverse-Binding Mechanism &gt;gi|429544198|pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353 &gt;gi|442570553|pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor &gt;gi|442570556|pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor &gt;gi|442570559|pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor &gt;gi|442570562|pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor &gt;gi|442570565|pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor &gt;gi|442570568|pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor &gt;gi|538260953|pdb|3VXE|H Chain H, Human Alpha-thrombin-bivalirudin Complex At Pd5.0 &gt;gi|538261034|pdb|4BOH|A Chain A, Madanins (merops I53) Are Cleaved By Thrombin And Factor Xa &gt;gi|538261036|pdb|4BOH|H Chain H, Madanins (merops I53) Are Cleaved By Thrombin And Factor Xa &gt;gi|550544495|pdb|4I7Y|H Chain H, Crystal Structure Of Human Alpha Thrombin In Complex With A 27-mer Aptamer Bound To Exosite Ii &gt;gi|564730922|pdb|4CH2|B Chain B, Low-salt Crystal Structure Of A Thrombin-gpibalpha Peptide Complex &gt;gi|564730924|pdb|4CH2|D Chain D, Low-salt Crystal Structure Of A Thrombin-gpibalpha Peptide Complex &gt;gi|564730931|pdb|4CH8|B Chain B, High-salt crystal structure of a thrombin-GpIbalpha peptide complex &gt;gi|564730932|pdb|4CH8|D Chain D, High-salt crystal structure of a thrombin-GpIbalpha peptide complex &gt;gi|564730933|pdb|4CH8|F Chain F, High-salt crystal structure of a thrombin-GpIbalpha peptide complex &gt;gi|564730934|pdb|4CH8|H Chain H, High-salt crystal structure of a thrombin-GpIbalpha peptide complex &gt;gi|572153289|pdb|4LZ1|H Chain H, X-ray structure of the complex between human thrombin and the TBA deletion mutant lacking thymine 12 nucleobase &gt;gi|572153292|pdb|4LZ4|B Chain B, X-ray structure of the complex between human thrombin and the TBA deletion mutant lacking thymine 3 nucleobase &gt;gi|572153294|pdb|4LZ4|D Chain D, X-ray structure of the complex between human thrombin and the TBA deletion mutant lacking thymine 3 nucleobase &gt;gi|651207651|pdb|4LXB|H Chain H, Crystal Structure Analysis Of Thrombin In Complex With Compound D58 &gt;gi|835020378|pdb|4YES|B Chain B, Thrombin In Complex With (s)-(4-chloro-2-((1-(5-methyl-1h-pyrrole-2- Carbonyl)pyrrolidine-2-carboxamido)methyl)phenyl)methanaminium &gt;gi|922664668|pdb|4UD9|H Chain H, Thrombin in complex with 5-chlorothiophene-2-carboxamide &gt;gi|943352218|pdb|5E8E|H Chain H, Crystal Structure Of Thrombin Bound To An Exosite 1-specific Iga Fab &gt;gi|973744219|pdb|5CMX|H Chain H, X-ray Structure Of The Complex Between Human Alpha Thrombin And A Duplex/quadruplex 31-mer Dna Aptamer &gt;gi|1109303988|pdb|5EW1|H Chain H, Human Thrombin Sandwiched Between Two Dna Aptamers: Hd22 And Hd1- Deltat3 &gt;gi|1109303992|pdb|5EW2|H Chain H, Human Thrombin Sandwiched Between Two Dna Aptamers: Hd22 And Hd1- Deltat12 &gt;gi|1173195537|pdb|5L6N|H Chain H, Disulfated Madanin-thrombin Complex &gt;gi|1189450145|pdb|5GIM|B Chain B, Crystal Structure Of Thrombin-avathrin Complex &gt;gi|1199299157|pdb|5JFD|H Chain H, Thrombin in complex with (S)-N-(2-(aminomethyl)-5-chlorobenzyl)-1-((benzylsulfonyl)-D-arginyl)pyrrolidine-2-carboxamide &gt;gi|1201295282|pdb|5JZY|H Chain H, Thrombin In Complex With (s)-1-((r)-2-amino-3-cyclohexylpropanoyl)-n- (4-carbamimidoylbenzyl)pyrrolidine-2-carboxamide &gt;gi|1208077106|pdb|5NHU|H Chain H, Human Alpha Thrombin Complexed With Anopheles Gambiae Ce5 Anticoagulant &gt;gi|1208077108|pdb|5NHU|A Chain A, Human Alpha Thrombin Complexed With Anopheles Gambiae Ce5 Anticoagulant &gt;gi|1208077110|pdb|5NHU|C Chain C, Human Alpha Thrombin Complexed With Anopheles Gambiae Ce5 Anticoagulant &gt;gi|1220111717|pdb|5LCE|H Chain H, Thrombin In Complex With (s)-1-((r)-2-amino-3-cyclohexylpropanoyl)-n- (5-chloro-2-(hydroxymethyl)benzy L)pyrrolidine-2-carboxamide &gt;gi|1220111733|pdb|5LPD|H Chain H, Thrombin In Complex With (s)-1-((r)-2-amino-3-cyclohexylpropanoyl)-n- (2-(aminomethyl)-5-chlorobenzyl) Pyrrolidine-2-carboxamide &gt;gi|1270517011|pdb|6EO7|H Chain H, X-ray structure of the complex between human alpha-thrombin and modified 15-mer DNA aptamer containing 5-(3-(acetamide-N-yl)-1-propen-1-yl)-2&apos;-deoxyuridine residue &gt;gi|1272616015|pdb|6EO6|H Chain H, X-ray structure of the complex between human alpha-thrombin and modified 15-mer DNA aptamer containing 5-(3-(2-(1H-indol-3-yl)acetamide-N-yl)-1-propen-1-yl)-2&apos;-deoxyuridine residue &gt;gi|1285034018|pdb|3VXF|H Chain H, X/N Joint refinement of Human alpha-thrombin-Bivalirudin complex PD5 &gt;gi|1312331303|pdb|6EO8|H Chain H, Crystal structure of thrombin in complex with a novel glucose-conjugated potent inhibitor &gt;gi|1312331307|pdb|6EO9|H Chain H, Crystal structure of thrombin in complex with a novel glucose-conjugated potent inhibitor &gt;gi|1388258187|pdb|6CYM|A Chain A, Reversible Covalent Direct Thrombin Inhibitors &gt;gi|1388258189|pdb|6CYM|C Chain C, Reversible Covalent Direct Thrombin Inhibitors &gt;gi|1494592823|pdb|6GN7|H Chain H, Prothrombin &gt;gi|1498802850|pdb|6EVV|H Chain H, Prothrombin</Hit_def>
  <Hit_accession>1ABI_H</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>170.629</Hsp_bit-score>
      <Hsp_score>431</Hsp_score>
      <Hsp_evalue>1.8286e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>17</Hit_num>
  <Hit_id>gi|157880622|pdb|1WBG|B</Hit_id>
  <Hit_def>Chain B, Active Site Thrombin Inhibitors</Hit_def>
  <Hit_accession>1WBG_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>170.629</Hsp_bit-score>
      <Hsp_score>431</Hsp_score>
      <Hsp_evalue>1.8286e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>18</Hit_num>
  <Hit_id>gi|48425307|pdb|1RD3|B</Hit_id>
  <Hit_def>Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k &gt;gi|48425309|pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k</Hit_def>
  <Hit_accession>1RD3_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>170.629</Hsp_bit-score>
      <Hsp_score>431</Hsp_score>
      <Hsp_evalue>1.84862e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>19</Hit_num>
  <Hit_id>gi|460417541|pdb|4H6S|B</Hit_id>
  <Hit_def>Chain B, Crystal Structure Of Thrombin Mutant E14ea/d14la/e18a/s195a</Hit_def>
  <Hit_accession>4H6S_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>170.629</Hsp_bit-score>
      <Hsp_score>431</Hsp_score>
      <Hsp_evalue>1.86886e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>20</Hit_num>
  <Hit_id>gi|1321390907|pdb|5MJT|H</Hit_id>
  <Hit_def>Chain H, Thrombin Mutant A190S in complex with (S) -1 - ((R) -2-amino-3,3-diphenylpropanoyl) -N- (3-chlorobenzyl) pyrrolidine-2-carboxamide &gt;gi|1321390992|pdb|5MLS|H Chain H, Thrombin Mutant A190S in complex with (S)-1-(D-phenylalanyl)-N-(3-chlorobenzyl)pyrrolidine-2-carboxamide &gt;gi|1321390998|pdb|5MM6|H Chain H, Thrombin Mutant A190S in complex with (S)-1-(D-phenylalanyl)-N-(4-carbamimidoylbenzyl)pyrrolidine-2-carboxamide</Hit_def>
  <Hit_accession>5MJT_H</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>170.629</Hsp_bit-score>
      <Hsp_score>431</Hsp_score>
      <Hsp_evalue>1.88931e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>21</Hit_num>
  <Hit_id>gi|767259490|pdb|4RKJ|B</Hit_id>
  <Hit_def>Chain B, Crystal Structure Of Thrombin Mutant S195t (free Form) &gt;gi|767259491|pdb|4RKO|B Chain B, Crystal Structure Of Thrombin Mutant S195t Bound With Ppack</Hit_def>
  <Hit_accession>4RKJ_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>170.629</Hsp_bit-score>
      <Hsp_score>431</Hsp_score>
      <Hsp_evalue>1.88931e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>22</Hit_num>
  <Hit_id>gi|15825721|pdb|1JOU|B</Hit_id>
  <Hit_def>Chain B, Crystal Structure Of Native S195a Thrombin With An Unoccupied Active Site &gt;gi|15825723|pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An Unoccupied Active Site &gt;gi|15825725|pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An Unoccupied Active Site &gt;gi|52695710|pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The Antithrombin-Thrombin-Heparin Ternary Complex &gt;gi|116666780|pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two S195a Thrombin Molecules &gt;gi|116666782|pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two S195a Thrombin Molecules &gt;gi|185177830|pdb|3B9F|H Chain H, 1.6 A structure of the PCI-thrombin-heparin complex &gt;gi|256032633|pdb|3GIS|B Chain B, Crystal Structure Of Na-free Thrombin In Complex With Thrombomodulin &gt;gi|256032635|pdb|3GIS|D Chain D, Crystal Structure Of Na-free Thrombin In Complex With Thrombomodulin &gt;gi|256032637|pdb|3GIS|F Chain F, Crystal Structure Of Na-free Thrombin In Complex With Thrombomodulin &gt;gi|291191316|pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In Complex Extracellular Fragment Of Human Par1 &gt;gi|291191319|pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In Complex Extracellular Fragment Of Human Par1 &gt;gi|386783415|pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation Domain Qedqvdprlidgkmtrrgds Of Protein C &gt;gi|386783417|pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation Domain Qedqvdprlidgkmtrrgds Of Protein C &gt;gi|400977419|pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With S195a Thrombin &gt;gi|400977422|pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With S195a Thrombin &gt;gi|460417547|pdb|4HFP|B Chain B, Structure Of Thrombin Mutant S195a Bound To The Active Site Inhibitor Argatroban &gt;gi|460417549|pdb|4HFP|D Chain D, Structure Of Thrombin Mutant S195a Bound To The Active Site Inhibitor Argatroban</Hit_def>
  <Hit_accession>1JOU_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>170.629</Hsp_bit-score>
      <Hsp_score>431</Hsp_score>
      <Hsp_evalue>1.88931e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>23</Hit_num>
  <Hit_id>gi|6980506|pdb|1DM4|B</Hit_id>
  <Hit_def>Chain B, SER195ALA MUTANT OF HUMAN THROMBIN COMPLEXED WITH FIBRINOPEPTIDE A (7-16) &gt;gi|23200175|pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a Thrombin Complex</Hit_def>
  <Hit_accession>1DM4_B</Hit_accession>
  <Hit_len>260</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>170.629</Hsp_bit-score>
      <Hsp_score>431</Hsp_score>
      <Hsp_evalue>1.90192e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>75</Hsp_hit-from>
      <Hsp_hit-to>155</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>24</Hit_num>
  <Hit_id>gi|7767161|pdb|1DX5|M</Hit_id>
  <Hit_def>Chain M, Crystal structure of the thrombin-thrombomodulin complex &gt;gi|7767162|pdb|1DX5|N Chain N, Crystal structure of the thrombin-thrombomodulin complex &gt;gi|7767163|pdb|1DX5|O Chain O, Crystal structure of the thrombin-thrombomodulin complex &gt;gi|7767164|pdb|1DX5|P Chain P, Crystal structure of the thrombin-thrombomodulin complex &gt;gi|11513803|pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-thrombin-haemadin Complex: An Exosite Ii-binding Inhibitor &gt;gi|11513810|pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-thrombin-haemadin Complex: An Exosite Ii-binding Inhibitor &gt;gi|12084784|pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-thrombin-haemadin Complex: An Exosite Ii-binding Inhibitor</Hit_def>
  <Hit_accession>1DX5_M</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>170.629</Hsp_bit-score>
      <Hsp_score>431</Hsp_score>
      <Hsp_evalue>1.90999e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>25</Hit_num>
  <Hit_id>gi|20663562|pdb|1GJ5|H</Hit_id>
  <Hit_def>Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa, Ser190/ala190 Protease, Structure-based Drug Design &gt;gi|49258947|pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1 4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain Mimetics &gt;gi|159795118|pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin &gt;gi|212374978|pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human Thrombin &gt;gi|449113576|pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa, Ser190/ala190 Protease, Structure-based Drug Design &gt;gi|922664671|pdb|4UDW|H Chain H, Thrombin in complex with 1-(2R)-2-amino-3-phenyl-propanoyl-N-(2, 5dichlorophenyl)methylpyrrolidine-2-carboxamide &gt;gi|922664674|pdb|4UE7|H Chain H, Thrombin in complex with 1-amidinopiperidine &gt;gi|922664677|pdb|4UEH|H Chain H, Thrombin in complex with benzamidine &gt;gi|922664932|pdb|5AF9|H Chain H, Thrombin in complex with 4-Methoxy-N-(2-pyridinyl)benzamide &gt;gi|922664935|pdb|5AFY|H Chain H, Thrombin In Complex With 3-chloro-benzamide &gt;gi|922664938|pdb|5AFZ|H Chain H, Thrombin In Complex With (2r)-2-(benzylsulfonylamino)-n-(2-((4-carbamimidoylphenyl)methylamino)-2-oxo-propyl)-3-phenyl- Propanamide &gt;gi|922664941|pdb|5AHG|H Chain H, Thrombin in complex with ((4-chlorophenyl)sulfamoyl))diemethylamine &gt;gi|984076594|pdb|4UFD|H Chain H, Thrombin In Complex With 4-(((1-((2s)-1-((2r)-2-(Benzylsulfonylamino)-3-phenyl-propanoyl)pyrrolidin-2-yl)-1- Oxo-ethyl)amino)methyl)benzamidine &gt;gi|984076597|pdb|4UFE|H Chain H, Thrombin In Complex With (2r)-2-(benzylsulfonylamino)-n-(2-((4-carbamimidoylphenyl)methylamino)-2-oxo-butyl)-3-phenyl- Propanamide &gt;gi|984076600|pdb|4UFF|H Chain H, Thrombin In Complex With (2r)-2-(benzylsulfonylamino)-n-(2-((4-carbamimidoylphenyl)methylamino)-2-oxo-ethyl)-n-methyl- 3-phenyl-propanamide &gt;gi|984076603|pdb|4UFG|H Chain H, Thrombin In Complex With (2r)-2-(benzylsulfonylamino)-n-((1s)-2-((4-carbamimidoylphenyl)methylamino)-1-methyl-2-oxo- Ethyl)-n-methyl-3-phenyl-propanamide Ethane &gt;gi|1033647361|pdb|5A2M|H Chain H, Thrombin Inhibitor &gt;gi|1064245305|pdb|5DO4|H Chain H, Thrombin-rna Aptamer Complex</Hit_def>
  <Hit_accession>1GJ5_H</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>170.629</Hsp_bit-score>
      <Hsp_score>431</Hsp_score>
      <Hsp_evalue>1.91804e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>26</Hit_num>
  <Hit_id>gi|4699865|pdb|1THP|B</Hit_id>
  <Hit_def>Chain B, STRUCTURE OF HUMAN ALPHA-THROMBIN Y225P MUTANT BOUND TO D-PHE-PRO-ARG-CHLOROMETHYLKETONE &gt;gi|339717657|pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form &gt;gi|339717659|pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form &gt;gi|339717661|pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form</Hit_def>
  <Hit_accession>1THP_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>170.629</Hsp_bit-score>
      <Hsp_score>431</Hsp_score>
      <Hsp_evalue>1.97341e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>27</Hit_num>
  <Hit_id>gi|67464373|pdb|1Z8J|B</Hit_id>
  <Hit_def>Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To Ppack</Hit_def>
  <Hit_accession>1Z8J_B</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>170.629</Hsp_bit-score>
      <Hsp_score>431</Hsp_score>
      <Hsp_evalue>1.99501e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>28</Hit_num>
  <Hit_id>gi|4139650|pdb|1VR1|H</Hit_id>
  <Hit_def>Chain H, Specifity For Plasminogen Activator Inhibitor-1</Hit_def>
  <Hit_accession>1VR1_H</Hit_accession>
  <Hit_len>261</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>170.629</Hsp_bit-score>
      <Hsp_score>431</Hsp_score>
      <Hsp_evalue>2.04375e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>78</Hsp_hit-from>
      <Hsp_hit-to>158</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>29</Hit_num>
  <Hit_id>gi|38018090|gb|AAR08142.1|</Hit_id>
  <Hit_def>prothrombin, partial [Homo sapiens]</Hit_def>
  <Hit_accession>AAR08142</Hit_accession>
  <Hit_len>295</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.785</Hsp_bit-score>
      <Hsp_score>434</Hsp_score>
      <Hsp_evalue>2.12689e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>110</Hsp_hit-from>
      <Hsp_hit-to>190</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>30</Hit_num>
  <Hit_id>gi|206725485|ref|NP_001126851.1|</Hit_id>
  <Hit_def>prothrombin precursor [Pongo abelii] &gt;gi|62511155|sp|Q5R537.1|THRB_PONAB RecName: Full=Prothrombin; AltName: Full=Coagulation factor II; Contains: RecName: Full=Activation peptide fragment 1; Contains: RecName: Full=Activation peptide fragment 2; Contains: RecName: Full=Thrombin light chain; Contains: RecName: Full=Thrombin heavy chain; Flags: Precursor &gt;gi|55732873|emb|CAH93129.1| hypothetical protein [Pongo abelii]</Hit_def>
  <Hit_accession>NP_001126851</Hit_accession>
  <Hit_len>623</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>179.104</Hsp_bit-score>
      <Hsp_score>453</Hsp_score>
      <Hsp_evalue>2.43417e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>438</Hsp_hit-from>
      <Hsp_hit-to>518</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>31</Hit_num>
  <Hit_id>gi|27065656|pdb|1MH0|A</Hit_id>
  <Hit_def>Chain A, Crystal Structure Of The Anticoagulant Slow Form Of Thrombin &gt;gi|27065657|pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of Thrombin</Hit_def>
  <Hit_accession>1MH0_A</Hit_accession>
  <Hit_len>287</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.014</Hsp_bit-score>
      <Hsp_score>432</Hsp_score>
      <Hsp_evalue>2.6706e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>104</Hsp_hit-from>
      <Hsp_hit-to>184</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>32</Hit_num>
  <Hit_id>gi|1331920496|gb|PNJ68410.1|</Hit_id>
  <Hit_def>F2 isoform 1 [Pongo abelii]</Hit_def>
  <Hit_accession>PNJ68410</Hit_accession>
  <Hit_len>623</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>178.718</Hsp_bit-score>
      <Hsp_score>452</Hsp_score>
      <Hsp_evalue>2.67288e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>438</Hsp_hit-from>
      <Hsp_hit-to>518</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>33</Hit_num>
  <Hit_id>gi|460417542|pdb|4H6T|A</Hit_id>
  <Hit_def>Chain A, Crystal Structure Of Prethrombin-2 Mutant E14ea/d14la/e18a/s195a</Hit_def>
  <Hit_accession>4H6T_A</Hit_accession>
  <Hit_len>306</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.785</Hsp_bit-score>
      <Hsp_score>434</Hsp_score>
      <Hsp_evalue>2.76492e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>121</Hsp_hit-from>
      <Hsp_hit-to>201</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>34</Hit_num>
  <Hit_id>gi|809450|pdb|1HAG|E</Hit_id>
  <Hit_def>Chain E, THE ISOMORPHOUS STRUCTURES OF PRETHROMBIN2, HIRUGEN-AND PPACK-THROMBIN: CHANGES ACCOMPANYING ACTIVATION AND EXOSITE BINDING TO THROMBIN &gt;gi|11514051|pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex At 1.7 A &gt;gi|67464458|pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex &gt;gi|656339591|gb|AID16054.1| prethrombin 2delta13, partial [synthetic construct]</Hit_def>
  <Hit_accession>1HAG_E</Hit_accession>
  <Hit_len>295</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.4</Hsp_bit-score>
      <Hsp_score>433</Hsp_score>
      <Hsp_evalue>2.91367e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>110</Hsp_hit-from>
      <Hsp_hit-to>190</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>35</Hit_num>
  <Hit_id>gi|11514286|pdb|1D6W|A</Hit_id>
  <Hit_def>Chain A, Structure Of Thrombin Complexed With Selective Non-electrophilic Inhibitors Having Cyclohexyl Moieties At P1 &gt;gi|14278416|pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With Bch-10556 And Exosite-directed Peptide</Hit_def>
  <Hit_accession>1D6W_A</Hit_accession>
  <Hit_len>287</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.014</Hsp_bit-score>
      <Hsp_score>432</Hsp_score>
      <Hsp_evalue>3.07558e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>104</Hsp_hit-from>
      <Hsp_hit-to>184</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>36</Hit_num>
  <Hit_id>gi|307776409|pdb|3K65|B</Hit_id>
  <Hit_def>Chain B, Crystal Structure Of Prethombin-2/fragment-2 Complex</Hit_def>
  <Hit_accession>3K65_B</Hit_accession>
  <Hit_len>308</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.785</Hsp_bit-score>
      <Hsp_score>434</Hsp_score>
      <Hsp_evalue>3.11153e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>123</Hsp_hit-from>
      <Hsp_hit-to>203</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>37</Hit_num>
  <Hit_id>gi|37927039|pdb|1NU9|A</Hit_id>
  <Hit_def>Chain A, Staphylocoagulase-prethrombin-2 Complex &gt;gi|37927041|pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex</Hit_def>
  <Hit_accession>1NU9_A</Hit_accession>
  <Hit_len>291</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.014</Hsp_bit-score>
      <Hsp_score>432</Hsp_score>
      <Hsp_evalue>3.14433e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>106</Hsp_hit-from>
      <Hsp_hit-to>186</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>38</Hit_num>
  <Hit_id>gi|656339593|gb|AID16055.1|</Hit_id>
  <Hit_def>prethrombin 2, partial [synthetic construct]</Hit_def>
  <Hit_accession>AID16055</Hit_accession>
  <Hit_len>308</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.785</Hsp_bit-score>
      <Hsp_score>434</Hsp_score>
      <Hsp_evalue>3.14544e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>123</Hsp_hit-from>
      <Hsp_hit-to>203</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>39</Hit_num>
  <Hit_id>gi|7766841|pdb|1EOJ|A</Hit_id>
  <Hit_def>Chain A, ALPHA THROMBIN &gt;gi|7766843|pdb|1EOL|A Chain A, ALPHA THROMBIN</Hit_def>
  <Hit_accession>1EOJ_A</Hit_accession>
  <Hit_len>289</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.014</Hsp_bit-score>
      <Hsp_score>432</Hsp_score>
      <Hsp_evalue>3.24806e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>106</Hsp_hit-from>
      <Hsp_hit-to>186</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>40</Hit_num>
  <Hit_id>gi|118137345|pdb|2BDY|A</Hit_id>
  <Hit_def>Chain A, Thrombin In Complex With Inhibitor</Hit_def>
  <Hit_accession>2BDY_A</Hit_accession>
  <Hit_len>289</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.014</Hsp_bit-score>
      <Hsp_score>432</Hsp_score>
      <Hsp_evalue>3.24806e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>104</Hsp_hit-from>
      <Hsp_hit-to>184</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>41</Hit_num>
  <Hit_id>gi|358439801|pdb|3SQE|E</Hit_id>
  <Hit_def>Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The Alternative Form &gt;gi|358439811|pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The Open Form &gt;gi|704360998|pdb|4RN6|A Chain A, Structure Of Prethrombin-2 Mutant S195a Bound To The Active Site Inhibitor Argatroban &gt;gi|704360999|pdb|4RN6|B Chain B, Structure Of Prethrombin-2 Mutant S195a Bound To The Active Site Inhibitor Argatroban</Hit_def>
  <Hit_accession>3SQE_E</Hit_accession>
  <Hit_len>290</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.014</Hsp_bit-score>
      <Hsp_score>432</Hsp_score>
      <Hsp_evalue>3.26599e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>105</Hsp_hit-from>
      <Hsp_hit-to>185</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>42</Hit_num>
  <Hit_id>gi|11514212|pdb|1D9I|A</Hit_id>
  <Hit_def>Chain A, Structure Of Thrombin Complexed With Selective Non-electophilic Inhibitors Having Cyclohexyl Moieties At P1</Hit_def>
  <Hit_accession>1D9I_A</Hit_accession>
  <Hit_len>288</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.014</Hsp_bit-score>
      <Hsp_score>432</Hsp_score>
      <Hsp_evalue>3.30104e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>104</Hsp_hit-from>
      <Hsp_hit-to>184</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>43</Hit_num>
  <Hit_id>gi|34810002|pdb|1NM6|A</Hit_id>
  <Hit_def>Chain A, thrombin in complex with selective macrocyclic inhibitor at 1.8A &gt;gi|34810004|pdb|1NT1|A Chain A, thrombin in complex with selective macrocyclic inhibitor &gt;gi|49259291|pdb|1TA2|A Chain A, Crystal structure of thrombin in complex with compound 1 &gt;gi|49259293|pdb|1TA6|A Chain A, Crystal structure of thrombin in complex with compound 14b &gt;gi|51247369|pdb|1SL3|A Chain A, crystal structue of Thrombin in complex with a potent P1 heterocycle-Aryl based inhibitor &gt;gi|67464365|pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex Structure &gt;gi|71042452|pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b &gt;gi|78101058|pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21 &gt;gi|78101061|pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2 &gt;gi|170292482|pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15</Hit_def>
  <Hit_accession>1NM6_A</Hit_accession>
  <Hit_len>287</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>171.014</Hsp_bit-score>
      <Hsp_score>432</Hsp_score>
      <Hsp_evalue>3.31852e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>103</Hsp_hit-from>
      <Hsp_hit-to>183</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>44</Hit_num>
  <Hit_id>gi|67624831|emb|CAJ01369.1|</Hit_id>
  <Hit_def>prothrombin [Homo sapiens]</Hit_def>
  <Hit_accession>CAJ01369</Hit_accession>
  <Hit_len>622</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>178.718</Hsp_bit-score>
      <Hsp_score>452</Hsp_score>
      <Hsp_evalue>3.49253e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>437</Hsp_hit-from>
      <Hsp_hit-to>517</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>45</Hit_num>
  <Hit_id>gi|1335344|emb|CAA23842.1|</Hit_id>
  <Hit_def>unnamed protein product, partial [Homo sapiens]</Hit_def>
  <Hit_accession>CAA23842</Hit_accession>
  <Hit_len>615</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>178.333</Hsp_bit-score>
      <Hsp_score>451</Hsp_score>
      <Hsp_evalue>3.53064e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>430</Hsp_hit-from>
      <Hsp_hit-to>510</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>46</Hit_num>
  <Hit_id>gi|119588383|gb|EAW67977.1|</Hit_id>
  <Hit_def>coagulation factor II (thrombin), isoform CRA_a [Homo sapiens]</Hit_def>
  <Hit_accession>EAW67977</Hit_accession>
  <Hit_len>615</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>178.333</Hsp_bit-score>
      <Hsp_score>451</Hsp_score>
      <Hsp_evalue>3.56757e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>430</Hsp_hit-from>
      <Hsp_hit-to>510</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>47</Hit_num>
  <Hit_id>gi|189066554|dbj|BAG35804.1|</Hit_id>
  <Hit_def>unnamed protein product [Homo sapiens]</Hit_def>
  <Hit_accession>BAG35804</Hit_accession>
  <Hit_len>622</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>178.333</Hsp_bit-score>
      <Hsp_score>451</Hsp_score>
      <Hsp_evalue>3.60315e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>437</Hsp_hit-from>
      <Hsp_hit-to>517</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>48</Hit_num>
  <Hit_id>gi|4503635|ref|NP_000497.1|</Hit_id>
  <Hit_def>prothrombin isoform 1 preproprotein [Homo sapiens] &gt;gi|135807|sp|P00734.2|THRB_HUMAN RecName: Full=Prothrombin; AltName: Full=Coagulation factor II; Contains: RecName: Full=Activation peptide fragment 1; Contains: RecName: Full=Activation peptide fragment 2; Contains: RecName: Full=Thrombin light chain; Contains: RecName: Full=Thrombin heavy chain; Flags: Precursor &gt;gi|18653448|gb|AAL77436.1|AF478696_1 coagulation factor II (thrombin) [Homo sapiens] &gt;gi|339641|gb|AAC63054.1| prothrombin [Homo sapiens] &gt;gi|119588385|gb|EAW67979.1| coagulation factor II (thrombin), isoform CRA_c [Homo sapiens] &gt;gi|307683135|dbj|BAJ21184.1| coagulation factor II, partial [synthetic construct]</Hit_def>
  <Hit_accession>NP_000497</Hit_accession>
  <Hit_len>622</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>178.333</Hsp_bit-score>
      <Hsp_score>451</Hsp_score>
      <Hsp_evalue>3.60315e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>437</Hsp_hit-from>
      <Hsp_hit-to>517</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>49</Hit_num>
  <Hit_id>gi|30802115|gb|AAH51332.1|</Hit_id>
  <Hit_def>Coagulation factor II (thrombin) [Homo sapiens] &gt;gi|190690599|gb|ACE87074.1| coagulation factor II (thrombin) protein, partial [synthetic construct] &gt;gi|190691961|gb|ACE87755.1| coagulation factor II (thrombin) protein [synthetic construct]</Hit_def>
  <Hit_accession>AAH51332</Hit_accession>
  <Hit_len>622</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>178.333</Hsp_bit-score>
      <Hsp_score>451</Hsp_score>
      <Hsp_evalue>3.60315e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>437</Hsp_hit-from>
      <Hsp_hit-to>517</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>50</Hit_num>
  <Hit_id>gi|426368156|ref|XP_004051078.1|</Hit_id>
  <Hit_def>PREDICTED: prothrombin [Gorilla gorilla gorilla]</Hit_def>
  <Hit_accession>XP_004051078</Hit_accession>
  <Hit_len>622</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>178.333</Hsp_bit-score>
      <Hsp_score>451</Hsp_score>
      <Hsp_evalue>3.71727e-51</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>437</Hsp_hit-from>
      <Hsp_hit-to>517</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>81</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>81</Hsp_align-len>
      <Hsp_qseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_qseq>
      <Hsp_hseq>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_hseq>
      <Hsp_midline>NIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
</Iteration_hits>
  <Iteration_stat>
    <Statistics>
      <Statistics_db-num>177587836</Statistics_db-num>
      <Statistics_db-len>438055503</Statistics_db-len>
      <Statistics_hsp-len>0</Statistics_hsp-len>
      <Statistics_eff-space>0</Statistics_eff-space>
      <Statistics_kappa>0.041</Statistics_kappa>
      <Statistics_lambda>0.267</Statistics_lambda>
      <Statistics_entropy>0.14</Statistics_entropy>
    </Statistics>
  </Iteration_stat>
</Iteration>
</BlastOutput_iterations>
</BlastOutput>
